APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Custom Peptide CDMO Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Custom Peptide CDMO Services Market Analysis and Forecast 2026-2032

Report ID 17410838023 May 2026185 pages

Choose your research edition.

Industry ResearchCustom Peptide CDMO Services Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Peptide CDMO Services Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Custom Peptide CDMO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Peptide CDMO Services Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Peptide CDMO Services Market Analysis and Forecast 2026-2032185 pages · $4,950 USD

Market perspective

The global Custom Peptide CDMO Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Custom Peptide CDMO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Custom Peptide CDMO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Custom Peptide CDMO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Custom Peptide CDMO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Custom Peptide CDMO Services include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic and ScinoPharm, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Custom Peptide CDMO Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Custom Peptide CDMO Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Custom Peptide CDMO Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Custom Peptide CDMO Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Custom Peptide CDMO Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Custom Peptide CDMO Services revenue, projected growth trends, production technology, application and end-user industry.

Custom Peptide CDMO Services Segment by Company

Bachem

CordenPharma

PolyPeptide

AmbioPharm

Genscript

Thermo Fisher

USV Peptides

Bio Basic

ScinoPharm

JPT

CBL

Piramal Pharma

CPC Scientific

Creative Peptides

Chinese Peptide Company

ChengDu ShengNuo Biotec

AppTec Co., Ltd.

GL Biochem

Custom Peptide CDMO Services Segment by Type

GMP Services

Non-GMP Services

Custom Peptide CDMO Services Segment by Application

Commercial

Scientific Research

Other

Custom Peptide CDMO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Peptide CDMO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Peptide CDMO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Peptide CDMO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Custom Peptide CDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Custom Peptide CDMO Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Peptide CDMO Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Custom Peptide CDMO Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. GMP Services Major Player Table 3. Non-GMP Services Major Player Table 4. Global Custom Peptide CDMO Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Commercial Major Player Table 6. Scientific Research Major Player Table 7. Other Major Player Table 8. Custom Peptide CDMO Services Industry Trends Table 9. Custom Peptide CDMO Services Industry Drivers Table 10. Custom Peptide CDMO Services Industry Opportunities and Challenges Table 11. Custom Peptide CDMO Services Industry Restraints Table 12. Global Custom Peptide CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Custom Peptide CDMO Services Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Custom Peptide CDMO Services Market Share by Region (2021-2026) Table 15. Global Custom Peptide CDMO Services Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Custom Peptide CDMO Services Market Share by Region (2027-2032) Table 17. Global Custom Peptide CDMO Services Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Custom Peptide CDMO Services Revenue Market Share by Players (2021-2026) Table 19. Global Custom Peptide CDMO Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Custom Peptide CDMO Services Key Players Headquarters & Area Served Table 21. Global Custom Peptide CDMO Services Players, Product Type & Application Table 22. Global Custom Peptide CDMO Services Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Custom Peptide CDMO Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Custom Peptide CDMO Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Custom Peptide CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Custom Peptide CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Custom Peptide CDMO Services Revenue Market Share by Type (2021-2026) Table 29. Global Custom Peptide CDMO Services Revenue Market Share by Type (2027-2032) Table 30. Global Custom Peptide CDMO Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Custom Peptide CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Custom Peptide CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Custom Peptide CDMO Services Revenue Market Share by Application (2021-2026) Table 34. Global Custom Peptide CDMO Services Revenue Market Share by Application (2027-2032) Table 35. Bachem Company Information Table 36. Bachem Business Overview Table 37. Bachem Custom Peptide CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Bachem Custom Peptide CDMO Services Product Portfolio Table 39. Bachem Recent Development Table 40. CordenPharma Company Information Table 41. CordenPharma Business Overview Table 42. CordenPharma Custom Peptide CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. CordenPharma Custom Peptide CDMO Services Product Portfolio Table 44. CordenPharma Recent Development Table 45. PolyPeptide Company Information Table 46. PolyPeptide Business Overview Table 47. PolyPeptide Custom Peptide CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. PolyPeptide Custom Peptide CDMO Services Product Portfolio Table 49. PolyPeptide Recent Development Table 50. AmbioPharm Company Information Table 51. AmbioPharm Business Overview Table 52. AmbioPharm Custom Peptide CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. AmbioPharm Custom Peptide CDMO Services Product Portfolio Table 54. AmbioPharm Recent Development Table 55. Genscript Company Information Table 56. Genscript Business Overview Table 57. Genscript Custom Peptide CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Genscript Custom Peptide CDMO Services Product Portfolio Table 59. Genscript Recent Development Table 60. Thermo Fisher Company Information Table 61. Thermo Fisher Business Overview Table 62. Thermo Fisher Custom Peptide CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Thermo Fisher Custom Peptide CDMO Services Product Portfolio Table 64. Thermo Fisher Recent Development Table 65. USV Peptides Company Information Table 66. USV Peptides Business Overview Table 67. USV Peptides Custom Peptide CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. USV Peptides Custom Peptide CDMO Services Product Portfolio Table 69. USV Peptides Recent Development Table 70. Bio Basic Company Information Table 71. Bio Basic Business Overview Table 72. Bio Basic Custom Peptide CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Bio Basic Custom Peptide CDMO Services Product Portfolio Table 74. Bio Basic Recent Development Table 75. ScinoPharm Company Information Table 76. ScinoPharm Business Overview Table 77. ScinoPharm Custom Peptide CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. ScinoPharm Custom Peptide CDMO Services Product Portfolio Table 79. ScinoPharm Recent Development Table 80. JPT Company Information Table 81. JPT Business Overview Table 82. JPT Custom Peptide CDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. JPT Custom Peptide CDMO Services Product Portfolio Table 84. JPT Recent Development Table 85. CBL Company Information Table 86. CBL Business Overview Table 87. CBL Custom Peptide CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. CBL Custom Peptide CDMO Services Product Portfolio Table 89. CBL Recent Development Table 90. Piramal Pharma Company Information Table 91. Piramal Pharma Business Overview Table 92. Piramal Pharma Custom Peptide CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Piramal Pharma Custom Peptide CDMO Services Product Portfolio Table 94. Piramal Pharma Recent Development Table 95. CPC Scientific Company Information Table 96. CPC Scientific Business Overview Table 97. CPC Scientific Custom Peptide CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. CPC Scientific Custom Peptide CDMO Services Product Portfolio Table 99. CPC Scientific Recent Development Table 100. Creative Peptides Company Information Table 101. Creative Peptides Business Overview Table 102. Creative Peptides Custom Peptide CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Creative Peptides Custom Peptide CDMO Services Product Portfolio Table 104. Creative Peptides Recent Development Table 105. Chinese Peptide Company Company Information Table 106. Chinese Peptide Company Business Overview Table 107. Chinese Peptide Company Custom Peptide CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Chinese Peptide Company Custom Peptide CDMO Services Product Portfolio Table 109. Chinese Peptide Company Recent Development Table 110. ChengDu ShengNuo Biotec Company Information Table 111. ChengDu ShengNuo Biotec Business Overview Table 112. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product Portfolio Table 114. ChengDu ShengNuo Biotec Recent Development Table 115. AppTec Co., Ltd. Company Information Table 116. AppTec Co., Ltd. Business Overview Table 117. AppTec Co., Ltd. Custom Peptide CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. AppTec Co., Ltd. Custom Peptide CDMO Services Product Portfolio Table 119. AppTec Co., Ltd. Recent Development Table 120. GL Biochem Company Information Table 121. GL Biochem Business Overview Table 122. GL Biochem Custom Peptide CDMO Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. GL Biochem Custom Peptide CDMO Services Product Portfolio Table 124. GL Biochem Recent Development Table 125. North America Custom Peptide CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 126. North America Custom Peptide CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 127. North America Custom Peptide CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 128. North America Custom Peptide CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 129. North America Custom Peptide CDMO Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Custom Peptide CDMO Services Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Custom Peptide CDMO Services Revenue by Country (US$ Million) & (2027-2032) Table 132. Europe Custom Peptide CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Custom Peptide CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Custom Peptide CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Custom Peptide CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Custom Peptide CDMO Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Custom Peptide CDMO Services Revenue by Country (2021-2026) & (US$ Million) Table 138. Europe Custom Peptide CDMO Services Revenue by Country (US$ Million) & (2027-2032) Table 139. China Custom Peptide CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 140. China Custom Peptide CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 141. China Custom Peptide CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 142. China Custom Peptide CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Custom Peptide CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Custom Peptide CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Custom Peptide CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Custom Peptide CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Custom Peptide CDMO Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Custom Peptide CDMO Services Revenue by Region (US$ Million) & (2021-2026) Table 149. Asia Custom Peptide CDMO Services Revenue by Region (US$ Million) & (2027-2032) Table 150. SAMEA Custom Peptide CDMO Services Revenue by Type (2021-2026) & (US$ Million) Table 151. SAMEA Custom Peptide CDMO Services Revenue by Type (2027-2032) & (US$ Million) Table 152. SAMEA Custom Peptide CDMO Services Revenue by Application (2021-2026) & (US$ Million) Table 153. SAMEA Custom Peptide CDMO Services Revenue by Application (2027-2032) & (US$ Million) Table 154. SAMEA Custom Peptide CDMO Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. SAMEA Custom Peptide CDMO Services Revenue by Country (2021-2026) & (US$ Million) Table 156. SAMEA Custom Peptide CDMO Services Revenue by Country (US$ Million) & (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Custom Peptide CDMO Services Image Figure 2. Global Custom Peptide CDMO Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Peptide CDMO Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. GMP Services Image Figure 5. Non-GMP Services Image Figure 6. Global Custom Peptide CDMO Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Custom Peptide CDMO Services Market Size Share 2021 VS 2025 VS 2032 Figure 8. Commercial Image Figure 9. Scientific Research Image Figure 10. Other Image Figure 11. Global Custom Peptide CDMO Services Market Size (US$ Million) & (2021-2032) Figure 12. Global Custom Peptide CDMO Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Custom Peptide CDMO Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Custom Peptide CDMO Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Custom Peptide CDMO Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Custom Peptide CDMO Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Custom Peptide CDMO Services Revenue Market Share by Type (2021-2032) Figure 19. Global Custom Peptide CDMO Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Custom Peptide CDMO Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Custom Peptide CDMO Services Revenue Market Share by Application (2021-2032) Figure 22. North America Custom Peptide CDMO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Custom Peptide CDMO Services Revenue Share by Type (2021-2032) Figure 24. North America Custom Peptide CDMO Services Revenue Share by Application (2021-2032) Figure 25. North America Custom Peptide CDMO Services Revenue Share by Country (2021-2032) Figure 26. United States Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Custom Peptide CDMO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Custom Peptide CDMO Services Revenue Share by Type (2021-2032) Figure 31. Europe Custom Peptide CDMO Services Revenue Share by Application (2021-2032) Figure 32. Europe Custom Peptide CDMO Services Revenue Share by Country (2021-2032) Figure 33. Germany Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Custom Peptide CDMO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Custom Peptide CDMO Services Revenue Share by Type (2021-2032) Figure 43. China Custom Peptide CDMO Services Revenue Share by Application (2021-2032) Figure 44. Asia Custom Peptide CDMO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Custom Peptide CDMO Services Revenue Share by Type (2021-2032) Figure 46. Asia Custom Peptide CDMO Services Revenue Share by Application (2021-2032) Figure 47. Asia Custom Peptide CDMO Services Revenue Share by Region (2021-2032) Figure 48. Japan Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Custom Peptide CDMO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Custom Peptide CDMO Services Revenue Share by Type (2021-2032) Figure 56. SAMEA Custom Peptide CDMO Services Revenue Share by Application (2021-2032) Figure 57. SAMEA Custom Peptide CDMO Services Revenue Share by Country (2021-2032) Figure 58. Brazil Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Custom Peptide CDMO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • GMP Services
  • Non-GMP Services
Applications
  • Commercial
  • Scientific Research
  • Other
Companies covered
  • Bachem
  • CordenPharma
  • PolyPeptide
  • AmbioPharm
  • Genscript
  • Thermo Fisher
  • USV Peptides
  • Bio Basic
  • ScinoPharm
  • JPT
  • CBL
  • Piramal Pharma
  • CPC Scientific
  • Creative Peptides
  • Chinese Peptide Company
  • ChengDu ShengNuo Biotec
  • AppTec Co., Ltd.
  • GL Biochem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Custom Peptide CDMO Services Market by Type
  3. 1.2.1 Global Custom Peptide CDMO Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 GMP Services
  5. 1.2.3 Non-GMP Services
  6. 1.3 Custom Peptide CDMO Services Market by Application
  7. 1.3.1 Global Custom Peptide CDMO Services Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Commercial
  9. 1.3.3 Scientific Research
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Custom Peptide CDMO Services Market Dynamics
  1. 2.1 Custom Peptide CDMO Services Industry Trends
  2. 2.2 Custom Peptide CDMO Services Industry Drivers
  3. 2.3 Custom Peptide CDMO Services Industry Opportunities and Challenges
  4. 2.4 Custom Peptide CDMO Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Custom Peptide CDMO Services Market Perspective (2021-2032)
  2. 3.2 Global Custom Peptide CDMO Services Growth Trends by Region
  3. 3.2.1 Global Custom Peptide CDMO Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Custom Peptide CDMO Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Custom Peptide CDMO Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Custom Peptide CDMO Services Revenue by Players
  2. 4.1.1 Global Custom Peptide CDMO Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Custom Peptide CDMO Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Custom Peptide CDMO Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Custom Peptide CDMO Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Custom Peptide CDMO Services Key Players Headquarters & Area Served
  7. 4.4 Global Custom Peptide CDMO Services Players, Product Type & Application
  8. 4.5 Global Custom Peptide CDMO Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Custom Peptide CDMO Services Market CR5 and HHI
  11. 4.6.3 2025 Custom Peptide CDMO Services Tier 1, Tier 2, and Tier 3
5 Custom Peptide CDMO Services Market Size by Type
  1. 5.1 Global Custom Peptide CDMO Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Custom Peptide CDMO Services Revenue by Type (2021-2032)
  3. 5.3 Global Custom Peptide CDMO Services Revenue Market Share by Type (2021-2032)
6 Custom Peptide CDMO Services Market Size by Application
  1. 6.1 Global Custom Peptide CDMO Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Custom Peptide CDMO Services Revenue by Application (2021-2032)
  3. 6.3 Global Custom Peptide CDMO Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Bachem
  2. 7.1.1 Bachem Company Information
  3. 7.1.2 Bachem Business Overview
  4. 7.1.3 Bachem Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Bachem Custom Peptide CDMO Services Product Portfolio
  6. 7.1.5 Bachem Recent Developments
  7. 7.2 CordenPharma
  8. 7.2.1 CordenPharma Company Information
  9. 7.2.2 CordenPharma Business Overview
  10. 7.2.3 CordenPharma Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CordenPharma Custom Peptide CDMO Services Product Portfolio
  12. 7.2.5 CordenPharma Recent Developments
  13. 7.3 PolyPeptide
  14. 7.3.1 PolyPeptide Company Information
  15. 7.3.2 PolyPeptide Business Overview
  16. 7.3.3 PolyPeptide Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 PolyPeptide Custom Peptide CDMO Services Product Portfolio
  18. 7.3.5 PolyPeptide Recent Developments
  19. 7.4 AmbioPharm
  20. 7.4.1 AmbioPharm Company Information
  21. 7.4.2 AmbioPharm Business Overview
  22. 7.4.3 AmbioPharm Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AmbioPharm Custom Peptide CDMO Services Product Portfolio
  24. 7.4.5 AmbioPharm Recent Developments
  25. 7.5 Genscript
  26. 7.5.1 Genscript Company Information
  27. 7.5.2 Genscript Business Overview
  28. 7.5.3 Genscript Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Genscript Custom Peptide CDMO Services Product Portfolio
  30. 7.5.5 Genscript Recent Developments
  31. 7.6 Thermo Fisher
  32. 7.6.1 Thermo Fisher Company Information
  33. 7.6.2 Thermo Fisher Business Overview
  34. 7.6.3 Thermo Fisher Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Thermo Fisher Custom Peptide CDMO Services Product Portfolio
  36. 7.6.5 Thermo Fisher Recent Developments
  37. 7.7 USV Peptides
  38. 7.7.1 USV Peptides Company Information
  39. 7.7.2 USV Peptides Business Overview
  40. 7.7.3 USV Peptides Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 USV Peptides Custom Peptide CDMO Services Product Portfolio
  42. 7.7.5 USV Peptides Recent Developments
  43. 7.8 Bio Basic
  44. 7.8.1 Bio Basic Company Information
  45. 7.8.2 Bio Basic Business Overview
  46. 7.8.3 Bio Basic Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bio Basic Custom Peptide CDMO Services Product Portfolio
  48. 7.8.5 Bio Basic Recent Developments
  49. 7.9 ScinoPharm
  50. 7.9.1 ScinoPharm Company Information
  51. 7.9.2 ScinoPharm Business Overview
  52. 7.9.3 ScinoPharm Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 ScinoPharm Custom Peptide CDMO Services Product Portfolio
  54. 7.9.5 ScinoPharm Recent Developments
  55. 7.10 JPT
  56. 7.10.1 JPT Company Information
  57. 7.10.2 JPT Business Overview
  58. 7.10.3 JPT Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 JPT Custom Peptide CDMO Services Product Portfolio
  60. 7.10.5 JPT Recent Developments
  61. 7.11 CBL
  62. 7.11.1 CBL Company Information
  63. 7.11.2 CBL Business Overview
  64. 7.11.3 CBL Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 CBL Custom Peptide CDMO Services Product Portfolio
  66. 7.11.5 CBL Recent Developments
  67. 7.12 Piramal Pharma
  68. 7.12.1 Piramal Pharma Company Information
  69. 7.12.2 Piramal Pharma Business Overview
  70. 7.12.3 Piramal Pharma Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Piramal Pharma Custom Peptide CDMO Services Product Portfolio
  72. 7.12.5 Piramal Pharma Recent Developments
  73. 7.13 CPC Scientific
  74. 7.13.1 CPC Scientific Company Information
  75. 7.13.2 CPC Scientific Business Overview
  76. 7.13.3 CPC Scientific Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 CPC Scientific Custom Peptide CDMO Services Product Portfolio
  78. 7.13.5 CPC Scientific Recent Developments
  79. 7.14 Creative Peptides
  80. 7.14.1 Creative Peptides Company Information
  81. 7.14.2 Creative Peptides Business Overview
  82. 7.14.3 Creative Peptides Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Creative Peptides Custom Peptide CDMO Services Product Portfolio
  84. 7.14.5 Creative Peptides Recent Developments
  85. 7.15 Chinese Peptide Company
  86. 7.15.1 Chinese Peptide Company Company Information
  87. 7.15.2 Chinese Peptide Company Business Overview
  88. 7.15.3 Chinese Peptide Company Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Chinese Peptide Company Custom Peptide CDMO Services Product Portfolio
  90. 7.15.5 Chinese Peptide Company Recent Developments
  91. 7.16 ChengDu ShengNuo Biotec
  92. 7.16.1 ChengDu ShengNuo Biotec Company Information
  93. 7.16.2 ChengDu ShengNuo Biotec Business Overview
  94. 7.16.3 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product Portfolio
  96. 7.16.5 ChengDu ShengNuo Biotec Recent Developments
  97. 7.17 AppTec Co., Ltd.
  98. 7.17.1 AppTec Co., Ltd. Company Information
  99. 7.17.2 AppTec Co., Ltd. Business Overview
  100. 7.17.3 AppTec Co., Ltd. Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 AppTec Co., Ltd. Custom Peptide CDMO Services Product Portfolio
  102. 7.17.5 AppTec Co., Ltd. Recent Developments
  103. 7.18 GL Biochem
  104. 7.18.1 GL Biochem Company Information
  105. 7.18.2 GL Biochem Business Overview
  106. 7.18.3 GL Biochem Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 GL Biochem Custom Peptide CDMO Services Product Portfolio
  108. 7.18.5 GL Biochem Recent Developments
8 North America
  1. 8.1 North America Custom Peptide CDMO Services Revenue (2021-2032)
  2. 8.2 North America Custom Peptide CDMO Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Custom Peptide CDMO Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Custom Peptide CDMO Services Revenue by Type (2027-2032)
  5. 8.3 North America Custom Peptide CDMO Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Custom Peptide CDMO Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Custom Peptide CDMO Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Custom Peptide CDMO Services Revenue by Application (2027-2032)
  9. 8.5 North America Custom Peptide CDMO Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Custom Peptide CDMO Services Revenue by Country
  11. 8.6.1 North America Custom Peptide CDMO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Custom Peptide CDMO Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Custom Peptide CDMO Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Custom Peptide CDMO Services Revenue (2021-2032)
  2. 9.2 Europe Custom Peptide CDMO Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Custom Peptide CDMO Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Custom Peptide CDMO Services Revenue by Type (2027-2032)
  5. 9.3 Europe Custom Peptide CDMO Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Custom Peptide CDMO Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Custom Peptide CDMO Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Custom Peptide CDMO Services Revenue by Application (2027-2032)
  9. 9.5 Europe Custom Peptide CDMO Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Custom Peptide CDMO Services Revenue by Country
  11. 9.6.1 Europe Custom Peptide CDMO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Custom Peptide CDMO Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Custom Peptide CDMO Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Custom Peptide CDMO Services Revenue (2021-2032)
  2. 10.2 China Custom Peptide CDMO Services Revenue by Type (2021-2032)
  3. 10.2.1 China Custom Peptide CDMO Services Revenue by Type (2021-2026)
  4. 10.2.2 China Custom Peptide CDMO Services Revenue by Type (2027-2032)
  5. 10.3 China Custom Peptide CDMO Services Revenue Share by Type (2021-2032)
  6. 10.4 China Custom Peptide CDMO Services Revenue by Application (2021-2032)
  7. 10.4.1 China Custom Peptide CDMO Services Revenue by Application (2021-2026)
  8. 10.4.2 China Custom Peptide CDMO Services Revenue by Application (2027-2032)
  9. 10.5 China Custom Peptide CDMO Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Custom Peptide CDMO Services Revenue (2021-2032)
  2. 11.2 Asia Custom Peptide CDMO Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Custom Peptide CDMO Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Custom Peptide CDMO Services Revenue by Type (2027-2032)
  5. 11.3 Asia Custom Peptide CDMO Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Custom Peptide CDMO Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Custom Peptide CDMO Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Custom Peptide CDMO Services Revenue by Application (2027-2032)
  9. 11.5 Asia Custom Peptide CDMO Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Custom Peptide CDMO Services Revenue by Country
  11. 11.6.1 Asia Custom Peptide CDMO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Custom Peptide CDMO Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Custom Peptide CDMO Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Custom Peptide CDMO Services Revenue (2021-2032)
  2. 12.2 SAMEA Custom Peptide CDMO Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Custom Peptide CDMO Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Custom Peptide CDMO Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Custom Peptide CDMO Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Custom Peptide CDMO Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Custom Peptide CDMO Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Custom Peptide CDMO Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Custom Peptide CDMO Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Custom Peptide CDMO Services Revenue by Country
  11. 12.6.1 SAMEA Custom Peptide CDMO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Custom Peptide CDMO Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Custom Peptide CDMO Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst